Bayer Expands Levitra Marketing Rights Outside U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer purchases GlaxoSmithKline's co-promotion rights to the erectile dysfunction agent "in most major markets outside the U.S.," nearly four months after selling the U.S. marketing rights to its primary care products, including Levitra, to Schering-Plough.